Gilmartin Capital
Healthcare Investment FirmSan Francisco, United StatesSee on the mapgilmartincap.com
Health specialist
Gilmartin Capital invests in healthcare technology companies beyond proof of concept, including medical devices, life science tools, diagnostics, and digital health. It also supports companies working on scientific discovery and the cost, site, and delivery of care.
- 3
- Portfolio companies on reccy
- 2
- Hiring now
- 35
- Open roles in the portfolio
- Sep 2025
- Latest portfolio round
Hiring now in the portfolio35
Apply on each company's site- Posted 1d ago
Talent Acquisition Manager
SetPoint Medical · Valencia, CA
- Posted 1d ago
Buyer I
SetPoint Medical · Valencia, CA
- Added to reccy 4d ago
Medical Science Liaison - Southeast
Insightec · US, Remote
- Added to reccy 4d ago
Medical Science Liaison - Central
Insightec · US, Remote
- Added to reccy 4d ago
Field Service Specialist - National
Insightec · US, Remote
- Added to reccy 4d ago
Clinical Account Manager - New Jersey
Insightec · US, Remote
- Added to reccy 4d ago
Regional Sales Executive - Northcentral
Insightec · US, Remote
- Added to reccy 4d ago
Software QA Engineer
Insightec · Israel, Kiryat Ono
Portfolio on reccy3
From company funding recordsTheir companies, round by round
From company funding records- InsightecTirat Carmel, Israel
Focused ultrasound
- Jun 2024Private Equity · $150M
- Nov 2023Venture Round
- Sep 2022Debt Financing · $100M
- Nov 2021Series F
- Apr 2021Venture Round · $136M
- Nov 2020Corporate Round
- SetPoint MedicalValencia, California
Neuromodulation
- Aug 2025Series D · $115M
- Aug 2025Series C · $25M
- Mar 2025Venture Round · $12.4M
- Jan 2023Series C · $80M
- Jan 2023Debt Financing · $65M
- Jul 2021Debt Financing · $35M
- Galvanize Therapeutics, Inc.Redwood City, CA
- Nov 2026Series D · $130M
- Sep 2025Series C · $100MLed
- Sep 2022Series B · $100MLed
- Mar 2022Debt · $4M
- Mar 2022Series A · $3.4M
- Mar 2022Debt · $2M
Rounds marked Led list Gilmartin Capital as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Sep 2025
Galvanize Therapeutics, Inc. · Series C $100MLead
With Sofinnova Partners, Norwest Venture Partners, Elevage Medical Technologies, Ally Bridge Group, Perceptive Xontogeny Venture Fund, Janus Henderson Investors, Longaeva, Fidelity Management & Research Company, T. Rowe Price Associates, Apple Tree Partners
- Sep 2022
Galvanize Therapeutics, Inc. · Series B $100MLead
With Fidelity Investments, Fidelity Management & Research Company, Apple Tree Partners
Portfolio in the news
From the Cortex · last 12 months- Nov 2026
- Nov 2026
- Nov 2026
- Oct 2026
- Oct 2026
- Oct 2026